@anatagamuI'm not sure you realise this is a three-fold CR as you seem to think $500k is all they will have to spend for the next few months.
Tranche 1: To raise
$2,000,000 by issuing 222,222,222 @ 9c with 1 free attaching option for every 4 shares purchased (
Completed on Feb 15, 2021 with money in the bank)
Tranche 2: To raise
$1,000,000 by issuing 111,111,111 @ 9c with 1 free attaching option for every 4 shares purchased (To be completed April 8, 2021)
SPP: To raise
$500,000 by issuing by issuing 55,555,555 @9c with 1 free attaching option for every 4 shares purchased
Tranche 2 and SPP require shareholder approval. Both are fully underwritten too......a fancy way of saying the CR is a success even before it started (provided shareholder grant approval at GM). However, it will be a vote of confidence if shareholders take up the SPP.
I can't wait for the Compass money to start rolling in though. These funds should see us through the FDA trials and more. Any future CR (if necessary) should be way north of where we are now (hopefully)
